摘要
目的观察乙脑减毒活疫苗(SA14-14-2)(5人份/瓶)溶解稀释后病毒的稳定性。方法将该乙脑减毒活疫苗加入稀释液PBS(2.5ml/瓶),溶解稀释后分别置于2℃~8℃、20℃~25℃、37℃存放,在设置的不同时间点,分别测定病毒滴度,观察其病毒滴度变化趋势。结果该乙脑减毒活疫苗溶解稀释后在2℃~8℃、20℃~25℃存放至24h,在37℃存放至14h,病毒滴度下降,但符合《中国药典》2005年版的要求(≥5.7LgPFU/ml);在37℃存放大于14h后,病毒滴度下降明显,不符合《中国药典》2005年版的要求(≥5.7LgPFU/ml)。结论乙脑减毒活疫苗溶解稀释后在2℃~8℃、20℃~25℃可存放24h,在37℃可存放14h,其病毒滴度符合《中国药典》2005年版的要求(≥5.7LgPFU/ml)。
Objective To observe the stability of the JEV SA14-14-2 (5 doses)after dilution. Method We dissolved and diluted the JEV SA14-14-2 (5 doses)with PBS, then separated the samples and stored them in 3 different temperatures which were 2 ℃-8 ℃,20 ℃-25 ℃,37 ℃. After that, measured the PFU at the end of every point-time, and researched the change tendency.Results After dilution, the PFU of the JEV SA14-14-2 (5 doses)decreased, but the PFU was still according with the pharmacopoeia of PRC(≥5.7 LgPFU/ml), which was stored for 24 hours in 2 ℃-8 ℃,20 ℃-25 ℃,and stored for 14 hours in 37 ℃. After 14 hours, the PFU of sample which stored in 37 ℃decreased evidently, and it fell below the requirements of the pharmacopoeia of PRC(≥5.7 LgPFU/ml). Conclusion After dissolving and diluting, the PFU of the JEV SA14-14-2 (5 doses)accord with the pharmacopoeia of PRC(≥5.7 LgPFU/ml)in 2 ℃-8 ℃,20 ℃-25 ℃ for 24 hours and 37 ℃ for 14 hours.
出处
《预防医学情报杂志》
CAS
2007年第4期387-389,共3页
Journal of Preventive Medicine Information